Sweden· SE-20120218000051
Bretaris Genuair 322 mikrogram Inhalationspulver
A medicinal product containing aclidinium bromide, registered in Sweden by Covis Pharma Europe B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Aclidinium Bromide
- Manufacturer
- Covis Pharma Europe B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120218000051
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aclidinium bromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRETARIS GENUAIRCovis Pharma Europe B.V., Amsterdam
- BelgiumBretaris Genuair 322 µgCovis Pharma Europe
- NetherlandsBretaris Genuair 322 microgram inhalatiepoederCovis Pharma Europe B.V.
- PolandBretaris GenuairCovis Pharma Europe B.V.
- FinlandBretaris GenuairCOVIS PHARMA EUROPE B.V.
- IrelandBretaris Genuair 322 micrograms inhalation powderCovis Pharma Europe B.V.
- SpainEKLIRA GENUAIR 322 MICROGRAMOS POLVO PARA INHALACIONCovis Pharma Europe B.V.
- United KingdomAclidinium bromide 375micrograms/dose dry powder inhalerColorama Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bretaris Genuair, Eklira Genuair
- Liechtenstein · Bretaris Genuair, Eklira Genuair
- Norway · Bretaris Genuair, Eklira Genuair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6315001-edca-4b41-af24-e97f11004d74 GET /v1/drugs/b6315001-edca-4b41-af24-e97f11004d74?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20120218000051",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120218000051",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/bretaris-genuair-epar-product-information_sv.pdf"
}See everything about aclidinium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.